Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Global assessment of patient and caregiver unmet needs in myeloproliferative neoplasms (MPNs): Findings from the 2024 international assessment

View Full Paper
Ask AI
Bookmark
Share

Authors

KVKapila Viges

Discussion

Loading...

Member takes

Overview

Global assessment identifies unmet needs and priorities in myeloproliferative neoplasms, highlighting gaps in provider engagement and shared decision-making.

Key Points

  • Nearly half of respondents received care at academic medical centers, indicating varied treatment settings.
  • Fatigue was reported by 71% of participants, with quality of life being a key treatment priority for 52%.
  • Global assessment involving 676 individuals from 31 countries gauged unmet needs and treatment experiences.
  • The findings suggest a need for improved communication and alignment of care with patients' treatment goals.

Cite This Study

Kapila Viges (2025) studied this question.

synapsesocial.com/papers/69362f764fa91c937236e365https://doi.org/10.1182/blood-2025-966
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Access barriers and treatment patterns in Philadelphia-negative myeloproliferative neoplasms (Ph- MPN): Insights from a brazilian physician survey2025
  2. 2Patient and clinician perspectives on the diagnosis and management of polycythemia vera: Results from concurrent surveys2025
  3. 3Evaluating positive behavioral change in multiple myeloma: An MMRF longitudinal study.2025
  4. 4Health Distress and Challenges in Patients With Myeloproliferative Neoplasms During Follow‐Up Consultations at the Outpatient Clinic: A Phenomenological Study2025
  5. 5Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease‐directed progress2026